The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines", decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate LP-002459 dated 05/05/2014 issued to GlaxoSmithKline Trading, Russia):
Meropidel® (trade name of the medicinal product)
Meropenem (international non-proprietary or grouping or chemical name)
powder for the preparation of a solution for intravenous administration, 500 mg, 1000 mg (dosage form, dosage)
Agila Espelidades Pharmaceuticals LTD, Brazil Estrada Dr. Lourival Martins Beda № 1118, BAIRRO: Donana-Campos, dos Govtacazes, Rio De Janeiro (name and address of the location of the manufacturer of the medicinal product)
on the basis of a filing by an authorized legal entity of ZAO GlaxoSmithKline Trading, an application for the cancellation of the state registration of a medicinal product.